TONELLI, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 15.429
AS - Asia 8.715
EU - Europa 7.819
SA - Sud America 1.323
Continente sconosciuto - Info sul continente non disponibili 358
AF - Africa 226
OC - Oceania 74
Totale 33.944
Nazione #
US - Stati Uniti d'America 14.973
IT - Italia 3.331
SG - Singapore 2.761
CN - Cina 2.012
GB - Regno Unito 1.038
VN - Vietnam 1.003
BR - Brasile 961
HK - Hong Kong 869
DE - Germania 725
SE - Svezia 628
BD - Bangladesh 602
RU - Federazione Russa 363
FI - Finlandia 338
FR - Francia 330
CA - Canada 264
KR - Corea 252
IN - India 232
ID - Indonesia 217
NL - Olanda 190
AR - Argentina 139
TR - Turchia 138
JP - Giappone 134
UA - Ucraina 127
MX - Messico 122
BG - Bulgaria 87
ES - Italia 85
IE - Irlanda 80
PL - Polonia 73
IQ - Iraq 71
AU - Australia 67
ZA - Sudafrica 67
CO - Colombia 65
PK - Pakistan 63
LT - Lituania 56
AT - Austria 48
RO - Romania 48
AE - Emirati Arabi Uniti 44
EC - Ecuador 42
BE - Belgio 41
CL - Cile 41
CH - Svizzera 33
MA - Marocco 30
TW - Taiwan 30
CZ - Repubblica Ceca 29
MY - Malesia 29
EG - Egitto 27
VE - Venezuela 27
TH - Thailandia 26
JO - Giordania 25
UZ - Uzbekistan 23
SA - Arabia Saudita 22
DZ - Algeria 21
PH - Filippine 20
SI - Slovenia 20
IR - Iran 19
KE - Kenya 19
PY - Paraguay 19
GR - Grecia 18
NP - Nepal 17
CR - Costa Rica 16
TN - Tunisia 16
NO - Norvegia 15
PE - Perù 15
AZ - Azerbaigian 14
DK - Danimarca 14
HU - Ungheria 13
IL - Israele 13
JM - Giamaica 13
PT - Portogallo 13
KZ - Kazakistan 11
SN - Senegal 11
DO - Repubblica Dominicana 10
HR - Croazia 9
MD - Moldavia 9
OM - Oman 9
RS - Serbia 9
EE - Estonia 8
AL - Albania 7
GE - Georgia 7
LV - Lettonia 7
NZ - Nuova Zelanda 7
UY - Uruguay 7
BH - Bahrain 6
BY - Bielorussia 6
GA - Gabon 6
KG - Kirghizistan 6
LB - Libano 6
PA - Panama 6
BO - Bolivia 5
ET - Etiopia 5
LI - Liechtenstein 5
MK - Macedonia 5
PR - Porto Rico 5
PS - Palestinian Territory 5
QA - Qatar 5
SY - Repubblica araba siriana 5
A2 - ???statistics.table.value.countryCode.A2??? 4
LK - Sri Lanka 4
NG - Nigeria 4
NI - Nicaragua 4
Totale 33.526
Città #
Ashburn 1.855
Singapore 1.782
Santa Clara 1.497
Fairfield 1.279
Hong Kong 842
Chandler 840
San Jose 794
Council Bluffs 600
Woodbridge 595
Hefei 580
Houston 514
Seattle 471
Cambridge 408
Southend 399
Beijing 382
Wilmington 371
New York 362
London 360
Nyköping 349
Ho Chi Minh City 323
Milan 311
Ann Arbor 307
Los Angeles 300
Modena 274
Helsinki 242
Seoul 232
Hanoi 227
Chicago 222
San Diego 208
Bologna 193
Rome 190
Jakarta 188
The Dalles 173
Dearborn 160
Munich 158
Dallas 139
Jacksonville 126
Moscow 111
Shanghai 106
Lauterbourg 104
Tokyo 101
Buffalo 98
Princeton 96
São Paulo 96
Sofia 84
Orem 79
Toronto 78
Redwood City 68
Dublin 62
Grafing 62
Naples 61
Salt Lake City 61
Frankfurt am Main 60
Parma 60
Boardman 55
Warsaw 55
Mexico City 53
Turin 50
Montreal 49
Chennai 47
Mumbai 46
Nuremberg 46
Bremen 45
Atlanta 44
Da Nang 44
Elk Grove Village 44
Eugene 43
Lappeenranta 42
Poplar 41
Verona 41
Florence 40
Haiphong 39
North York 38
Denver 36
Phoenix 36
Reggio Emilia 36
Sydney 36
Rio de Janeiro 34
Brooklyn 33
Hangzhou 33
Johannesburg 33
Ankara 32
Brussels 32
Miami 32
Turku 32
Guangzhou 31
Hillsboro 31
Kent 30
Baghdad 29
Izmir 28
Stockholm 28
Tampa 28
Amsterdam 27
Boston 27
Des Moines 27
Redondo Beach 27
Dong Ket 26
Paris 26
Lahore 25
Fremont 24
Totale 21.321
Nome #
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 518
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 462
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with Covid-19 pneumonia. 440
Acute exacerbation of Idiopathic Pulmonary Fibrosis: lessons learned from the Acute Respiratory Distress Syndrome 429
Delirium and risk factors in patients undergoing non-invasive ventilation for de novo acute respiratory failure: an observational multicenter trial. 395
Insufficienza respiratoria acuta e cronica (cap.21). 386
Acute severe asthma: management and treatment. 384
Better prognosis in females with severe COVID-19 pneumonia: possible role of inflammation as potential mediator. 380
Effectiveness of pulmonary rehabilitation in patients with INTERSTITIAL LUNG DISEASE of different etiology: a multicenter prospective study 378
Cytomegalovirus blood reactivation in COVID-19 critically ill patients: risk factors and impact on mortality. 378
Machine learning in predicting respiratory failure in patients with COVID-19 pneumonia - challenges, strengths, and opportunities in a global health emergency. 372
Herpes Simplex re-activation in patients with SARS-CoV2 pneumonia: a prospective observational study. 370
An uncommon cause of hemoptysis: aortobronchial fistula. 367
Proteomics Analysis of Formalin-Fixed Paraffine-Embedded Tissue Reveals Key Proteins Related to Lung Dysfunction in Idiopathic Pulmonary Fibrosis. 365
Incidence, etiology and clinico-pathologic features of endobronchial benign lesions: 10 consecutive years rerospective study 350
When Acute Respiratory Distress Syndrome is not ARDS 348
The effect of bronchodilators on forced vital capacity measurement in patients with idiopathic pulmonary fibrosis 347
Integrated intErventional bronchoscopy in the treatment of locally adVanced non-small lung cancER with central Malignant airway Obstructions: a multicentric REtrospective study (EVERMORE). 340
Spontaneous breathing and evolving phenotypes of lung damage in patients with COVID-19. 340
An uncommon cause of pneumonia: The golden diagnosis 338
First and second waves among hospitalised patients with COVID-19 with severe pneumonia: a comparison of 28-day mortality over the 1-year pandemic in a tertiary university hospital in Italy 338
Breathlessness, but not cough, suggests chronic obstructive pulmonary disease in elderly smokers with stable heart failure 332
Hypokalemia in Patients with COVID-19 329
Ventilatory support and mechanical properties of the fibrotic lung acting as a “squishy ball” 328
Serial Ultrasound Assessment of Diaphragmatic Function and Clinical Outcome in Patients with Amyotrophic Lateral Sclerosis. 327
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 327
Prevalence and outcome of diaphragmatic dysfunction assessed by ultrasound technology during acute exacerbation of chronic obstructive pulmonary disease: a pilot study. 324
Use of Pirfenidone in Idiopathic Pulmonary Fibrosis: A Case Study 323
Molecular Mechanisms and Physiological Changes behind Benign Tracheal and Subglottic Stenosis in Adults 321
Use of adjunctive cardiovascular therapy in patients hospitalized for acute exacerbations of COPD. 320
Prevalence and development of chronic critical illness in acute patients admitted to a respiratory intensive care setting 318
Pulmonary stretch and lung mechanotransduction: Implications for progression in the fibrotic lung 318
Expression of HOXB7 in the lung of patients with idiopathic pulmonary fibrosis: a proof of concept study. 317
Molecular mechanisms and cellular contribution from lung fibrosis to lung cancer development. 314
Respiratory mechanics and diaphragmatic dysfunction in COPD patients who failed non-invasive mechanical ventilation 307
Breakthroughs in internal and respiratory medicine 306
Peritoneal dialysis in the time of coronavirus disease 2019 304
Early inspiratory effort assessment by esophageal manometry early predicts noninvasive ventilation outcome in de novo respiratory failure: a pilot study. 304
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 298
Novel drug targets for idiopathic pulmonary fibrosis 295
Fibrotic idiopathic interstitial lung disease: the molecular and cellular key players. 295
Inspiratory effort and respiratory mechanics in spontaneously breathing patients with acute exacerbation of idiopathic pulmonary fibrosis: a retrospective matched control study. 292
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 288
Subclinical liver fibrosis in patients with idiopathic pulmonary fibrosis 281
COPD exacerbation and diaphragmatic dysfunction: Conditions with mutual influence influencing outcomes? - Reply. 280
High flow nasal therapy versus noninvasive ventilation as initial ventilatory strategy in COPD exacerbation: a multicenter non-inferiority randomized trial 280
Early awake proning in critical and severe COVID-19 patients undergoing noninvasive respiratory support: A retrospective multicenter cohort study 280
Effects of cytokine blocking agents on hospital mortality in patients admitted to ICU with acute respiratory distress syndrome by SARS-CoV2 infection: retrospective cohort study. 275
Looking for a Chronic Care Model in COPD patients 272
Ultrasound assessed Diaphragm Impairment is a Predictor of Outcomes in Acute Exacerbation of Chronic Obstructive Pulmonary Disease undergoing Non-Invasive Ventilation. 270
COVIDGuide una app per il triage e l'autovalutazione della COVID-19. 269
The encaged lung: rapidly progressive idiopathic pleurisy. 268
Real-life comparison of Pirfenidone and Nintedanib in patients with Idiopathic Pulmonary Fibrosis: a 24-month assessment. 268
Never Give Up: lesson learned from a severe COVID-19 patient. 268
Development and validation of a prediction model for tocilizumab failure in hospitalized patients with SARS-CoV-2 infection 268
Atypical diagnosis for typical lung carcinoid 263
Effect of high flow nasal oxygen on inspiratory effort of patients with acute hypoxic respiratory failure and do not intubate order. 262
Ultrasound assessment of diaphragmatic function in patients with amyotrophic lateral sclerosis. 259
Nasal pressure swings as the measure of inspiratory effort in spontaneously breathing patients with de novo acute respiratory failure 259
The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease 253
Endobronchial valve positioning for alveolar-pleural fistula following ICU management of severe COVID-19 pneumonia. 253
Two fatal cases of acute liver failure due to HSV-1 infection in COVID-19 patients following immunomodulatory therapies. 252
Inspiratory effort and lung mechanics in spontaneously breathing patients with acute respiratory failure due to COVID-19. A matched control study. 252
STenting veRsus balloOn dilatation in patients with tracheal BEnign stenosis – the STROBE trial. 251
Proprietà meccaniche e comportamento elastico del polmone affetto da fibrosi con pattern "polmonite interstiziale tipica" in corso di ventilazione meccanica: sviluppo e significato clinico della teoria del polmone "squishy ball" 249
RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE. RADIOLOGICAL PATTERNS AND CORRELATIONS WITH CLINICAL, SEROLOGICAL AND DEMOGRAPHIC FEATURES OF DISEASE 247
Biological effects of COVID-19 on lung cancer: can we drive our decisions? 241
Etiology and Level of Lung Derangement Do Not Affect the Beneficial Effect of Pulmonary Rehabilitation in Patients with Interstitial Lung Diseases 241
Janus-faced amiodarone-induced pneumopathy 237
Endoscopic Bronchopleural Fistula Repair Using Autologous Fat Graft 236
The Effect Of Bronchodilators On Forced Vital Capacity In Patients With Idiopathic Pulmonary Fibrosis 233
Surfactant replacement might help recovery of low-compliance lung in severe COVID-19 pneumonia. 232
Idiopathic pulmonary fibrosis: diagnostic pitfalls and therapeutic challenges. 231
Response Letter to Tuffet S, et al. and to Michard F, et al. 229
Vanishing lung emphysema during chemotherapy for malignant pleural mesothelioma. 227
Changes in clinical characteristics and outcomes of patients admitted to inpatient cardiac rehabilitation 227
Dissecting the role of mesenchymal stem cells in idiopathic pulmonary fibrosis: cause or solution? 226
Impact of Mesenchymal Stromal/stem Cell Infusions on Circulating Inflammatory Biomarkers in COVID-19 Patients: Analysis of a Phase I-IIa Trial. 225
An Italian sacrifice to COVID-19 epidemic. 223
Impaired function in the complex patient with COPD: a matter to be considered 222
Erratum: Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature (Journal of Thoracic Disease (2019) 11 (1621-1628) DOI: 10.21037/jtd.2019.03.28) 220
Differences between acute exacerbations of idiopathic pulmonary fibrosis and other interstitial lung diseases. 215
The association of procalcitonin and C- reactive protein with bacterial infections acquired during ICU stay in COVID-19 critically ill patients. 214
Awaiting a cure for COVID-19: therapeutic approach in patients with different severity levels of COVID-19 214
Association Between Pulmonary Aspergillosis And Cytomegalovirus Reactivation In Critically Ill Covid-19 Patients: A Prospective Observational Cohort Study. 213
Accuracy of nasal pressure swing to predict failure of high flow nasal oxygen in patients with acute hypoxemic respiratory failure 209
Physiological effects of lung protective ventilation in patients with lung fibrosis and usual interstitial pneumonia pattern versus primary ARDS: a matched-control study. 209
Unusual effectiveness of systemic steroids in Whipple disease. 209
Assessing respiratory drive and inspiratory effort in critically ill patients at the bedside 208
An umbrella review of systematic reviews with meta-analyses evaluating positive and negative outcomes of Hydroxychloroquine and chloroquine therapy 206
Risk factors for pulmonary air leak and clinical prognosis in patients with COVID-19 related acute respiratory failure: a retrospective matched control study. 206
Monitoring and modulation of respiratory drive in patients with acute hypoxemic respiratory failure in spontaneous breathing 205
Feasibility and clinical impact of out-of-ICU noninvasive respiratory support in patients with COVID-19-related pneumonia 205
Correction: Endobronchial valve positioning for alveolar-pleural fistula following ICU management complicating COVID-19 pneumonia (BMC Pulmonary Medicine, (2021), 21, 1, (307), 10.1186/s12890-021-01653-w) 204
Extensive tracheal injuries: a reasoned multi-step approach to guarantee mechanical ventilatory support developed during COVID-19 pandemic. 202
Development of clinical tools to estimate the breathing effort during high-flow oxygen therapy: A multicenter cohort study 202
Endoscopic closure with double stenting and autologous fascia lata graft of large tracheo-esophageal fistula 200
Critical COVID-19 Patients Through First, Second And Third Wave: Retrospective Observational Study Comparing Outcomes In ICU. 200
Do All Critically Ill Patients with COVID-19 Disease Benefit from Adding Tocilizumab to Glucocorticoids? A Retrospective Cohort Study 199
Association between respiratory distress time and invasive mechanical ventilation in COVID-19 patients: a multicentre regional cohort study. 199
Totale 28.360
Categoria #
all - tutte 137.799
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 137.799


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.942 279 167 152 122 160 201 195 175 486 220 459 326
2022/20232.874 346 363 250 281 279 361 94 274 334 57 124 111
2023/20242.367 68 110 182 223 330 243 278 242 102 120 189 280
2024/20256.252 178 123 143 455 1.077 919 515 410 684 318 576 854
2025/202613.611 971 566 999 1.576 1.848 778 1.561 683 1.269 1.331 1.170 859
2026/2027529 529 0 0 0 0 0 0 0 0 0 0 0
Totale 33.944